iSpecimen Inc. (ISPC) Revenue History
Annual and quarterly revenue from 2018 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
ISPC Revenue Growth
Revenue Breakdown (FY 2025)
ISPC's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
ISPC Revenue Analysis (2018–2025)
As of May 8, 2026, iSpecimen Inc. (ISPC) generated trailing twelve-month (TTM) revenue of $1.9 million, reflecting significant decline in growth of -96.5% year-over-year. The most recent quarter (Q4 2025) recorded $51,761 in revenue, down 51.4% sequentially.
Looking at the longer-term picture, ISPC's 5-year compound annual growth rate (CAGR) stands at -25.1%, indicating revenue contraction over this period. The company achieved its highest annual revenue of $11.1 million in 2021.
Revenue diversification analysis shows ISPC's business is primarily driven by Product (90%), and Shipping and Handling (10%). With over half of revenue concentrated in Product, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including BRLT (+5.8% YoY), MEDP (+24.2% YoY), and BLFS (+40.9% YoY), ISPC has underperformed the peer group in terms of revenue growth. Compare ISPC vs BRLT →
ISPC Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| ISPCCurrent | $2M | -96.5% | -25.1% | -465.4% | |
 BRLT | $437M | +5.8% | +11.7% | -1.2% | |
 MEDP | $2.5B | +24.2% | +22.3% | 21.1% | |
 BLFS | $96M | +40.9% | +14.9% | -12.6% | |
 ICLR | $8.3B | -2.5% | +24.2% | 13.3% | |
 CRL | $4.0B | +0.1% | +6.5% | 12.6% |
ISPC Historical Revenue Data (2018–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $1.9M | -79.2% | $24K | 1.2% | $-8,977,919 | -465.4% |
| 2024 | $9.3M | -6.4% | $4.0M | 42.9% | $-12,728,045 | -137.0% |
| 2023 | $9.9M | -4.6% | $5.1M | 51.4% | $-11,169,349 | -112.5% |
| 2022 | $10.4M | -6.6% | $5.6M | 54.3% | $-10,186,082 | -97.9% |
| 2021 | $11.1M | +36.1% | $5.9M | 52.9% | $-5,925,246 | -53.2% |
| 2020 | $8.2M | +90.4% | $4.6M | 56.2% | $-2,406,380 | -29.4% |
| 2019 | $4.3M | -2.2% | $2.2M | 50.5% | $-3,880,089 | -90.3% |
| 2018 | $4.4M | - | $2.0M | 46.2% | $-3,356,301 | -76.4% |
See ISPC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ISPC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ISPC vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonISPC — Frequently Asked Questions
Quick answers to the most common questions about buying ISPC stock.
Is ISPC's revenue growth accelerating or slowing?
ISPC revenue declined -96.5% year-over-year, contrasting with the 5-year CAGR of -25.1%. TTM revenue fell to $2M. This reverses the prior growth trend.
What is ISPC's long-term revenue growth rate?
iSpecimen Inc.'s 5-year revenue CAGR of -25.1% reflects the variable expansion pattern. Current YoY growth of -96.5% is below this long-term average.
How is ISPC's revenue distributed by segment?
ISPC reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2018-2025 are available for download. Segment mix reveals concentration and diversification trends.